Clin Lab, BGI Genomics, Tianjin, 300308, China.
BGI Genomics, Shenzhen, 518083, China.
BMC Genomics. 2024 May 14;25(1):470. doi: 10.1186/s12864-024-10400-4.
The absence of heterozygosity (AOH) is a kind of genomic change characterized by a long contiguous region of homozygous alleles in a chromosome, which may cause human genetic disorders. However, no method of low-pass whole genome sequencing (LP-WGS) has been reported for the detection of AOH in a low-pass setting of less than onefold. We developed a method, termed CNVseq-AOH, for predicting the absence of heterozygosity using LP-WGS with ultra-low sequencing data, which overcomes the sparse nature of typical LP-WGS data by combing population-based haplotype information, adjustable sliding windows, and recurrent neural network (RNN). We tested the feasibility of CNVseq-AOH for the detection of AOH in 409 cases (11 AOH regions for model training and 863 AOH regions for validation) from the 1000 Genomes Project (1KGP). AOH detection using CNVseq-AOH was also performed on 6 clinical cases with previously ascertained AOHs by whole exome sequencing (WES).
Using SNP-based microarray results as reference (AOHs detected by CNVseq-AOH with at least a 50% overlap with the AOHs detected by chromosomal microarray analysis), 409 samples (863 AOH regions) in the 1KGP were used for concordant analysis. For 784 AOHs on autosomes and 79 AOHs on the X chromosome, CNVseq-AOH can predict AOHs with a concordant rate of 96.23% and 59.49% respectively based on the analysis of 0.1-fold LP-WGS data, which is far lower than the current standard in the field. Using 0.1-fold LP-WGS data, CNVseq-AOH revealed 5 additional AOHs (larger than 10 Mb in size) in the 409 samples. We further analyzed AOHs larger than 10 Mb, which is recommended for reporting the possibility of UPD. For the 291 AOH regions larger than 10 Mb, CNVseq-AOH can predict AOHs with a concordant rate of 99.66% with only 0.1-fold LP-WGS data. In the 6 clinical cases, CNVseq-AOH revealed all 15 known AOH regions.
Here we reported a method for analyzing LP-WGS data to accurately identify regions of AOH, which possesses great potential to improve genetic testing of AOH.
杂合性缺失(AOH)是一种基因组变化,其特征是染色体上的同一位点的纯合等位基因的长连续区域,可能导致人类遗传疾病。然而,目前还没有报道过在低至一倍的低覆盖度全基因组测序(LP-WGS)中检测 AOH 的方法。我们开发了一种方法,称为 CNVseq-AOH,用于使用超低测序数据的 LP-WGS 预测杂合性缺失,该方法通过结合基于群体的单倍型信息、可调节的滑动窗口和递归神经网络(RNN)来克服典型 LP-WGS 数据的稀疏性。我们在 1000 基因组计划(1KGP)的 409 例病例(11 个 AOH 区域用于模型训练和 863 个 AOH 区域用于验证)中测试了 CNVseq-AOH 检测 AOH 的可行性。我们还对 6 例临床病例进行了 AOH 检测,这些病例先前通过全外显子组测序(WES)确定了 AOH。
使用 SNP 芯片结果作为参考(CNVseq-AOH 检测到的 AOH 与通过染色体芯片分析检测到的 AOH 至少有 50%的重叠),对 1KGP 中的 409 例样本(863 个 AOH 区域)进行了一致性分析。对于常染色体上的 784 个 AOH 和 X 染色体上的 79 个 AOH,CNVseq-AOH 可以基于 0.1 倍 LP-WGS 数据的分析,分别以 96.23%和 59.49%的一致率预测 AOH,这远低于目前该领域的标准。使用 0.1 倍 LP-WGS 数据,CNVseq-AOH 在 409 例样本中发现了另外 5 个 AOH(大于 10 Mb)。我们进一步分析了大于 10 Mb 的 AOH,这是推荐报告 UPD 可能性的。对于大于 10 Mb 的 291 个 AOH 区域,CNVseq-AOH 仅使用 0.1 倍 LP-WGS 数据即可以 99.66%的一致率预测 AOH。在 6 例临床病例中,CNVseq-AOH 发现了所有 15 个已知的 AOH 区域。
在这里,我们报道了一种分析 LP-WGS 数据以准确识别 AOH 区域的方法,该方法具有极大的潜力来改善 AOH 的遗传检测。